5-HT1A receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-11C]WAY-100635

被引:18
|
作者
Sargent, Peter A. [1 ,2 ]
Rabiner, Eugenii A. [3 ]
Bhagwagar, Zubin [4 ]
Clark, Luke [5 ]
Cowen, Philip [1 ]
Goodwin, Guy M. [1 ]
Grasby, Paul M. [6 ]
机构
[1] Warneford Hosp, Univ Dept Psychiat, Oxford OX3 7JX, England
[2] Oxfordshire & Buckinghamshire Mental Hlth NHS Fdn, Oxford OX4 2GX, England
[3] Hammersmith Hosp, GlaxoSmithKline, Clin Imaging Ctr, London W12 0NN, England
[4] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA
[5] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England
[6] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Cyclotron Unit, MRC Clin Sci Ctr, London W12 0NN, England
基金
英国医学研究理事会;
关键词
Bipolar; Serotonin; Imaging; CHRONIC LITHIUM TREATMENT; MAJOR AFFECTIVE-DISORDERS; RAT-BRAIN; SEROTONERGIC NEUROTRANSMISSION; NEUROENDOCRINE RESPONSES; TRYPTOPHAN DEPLETION; SERUM CORTISOL; DEPRESSION; PET; RELEASE;
D O I
10.1016/j.jad.2009.07.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: This study was undertaken to examine whether brain 5-HT1A receptor binding is reduced in euthymic bipolar patients. Methods: Eight medicated euthymic bipolar patients and 8 healthy volunteers underwent positron emission tomography scanning using the selective 5-HT1A receptor radioligand [carbonyl-C-11]WAY-100635. Results: No significant difference in global postsynaptic parametric binding potential (BPND) was found between euthymic bipolar patients (mean +/- SD, 4.24 +/- 0.76) and healthy volunteers (mean +/- SD, 4.34 +/- 0.86). Ninety five percent Confidence Intervals for the difference in group mean global postsynaptic BPND were -0.77 to 0.97. Analysis of regional BPND did not reveal regional differences between patients and healthy controls. Limitations: The number of subjects studied was limited and all subjects were on medication. Conclusions: In contrast to previous findings of reduced 5-HT1A receptor binding in untreated unipolar and bipolar depressed patients [Sargent, PA., Kjaer, K.H., Bench, C.J., Rabiner, E.A., Messa, C., Meyer, J., Gunn, R.N., Grasby, P.M., Cowen, P.J., 2000. Brain serotonin1A receptor binding measured by positron emission tomography with [C-11]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry 57, 174-180]; [Drevets, W.C., Frank, E., Price, J.C., Kupfer, DJ., Holt, D., Greer, P.J., Huang, Y., Gautier, C., Mathis, C., 1999. PET imaging of serotonin1A receptor binding in depression. Biol. Psychiatry 46, 1375-1387] and in recovered unipolar depressed patients [Bhagwagar, Z., Rabiner, E.A., Sargent, P.A., Grasby, P.M., Cowen, P.J., 2004. Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [C-11]WAY-100635. Mol. Psychiatry 9, 386-92], this study found no difference in 5-HT1A receptor BPND between medicated euthymic bipolar patients and healthy controls. Normal 5-HT1A receptor BPND in these patients may be a result of drug treatment or could indicate that reduced 5-HT1A receptor binding is specific to the depressed state in bipolar patients. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 50 条
  • [1] Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-11C]WAY-100635 -: considerations on the validity of cerebellum as a reference region
    Hirvonen, Jussi
    Kajander, J.
    Allonen, T.
    Oikonen, V.
    Nagren, K.
    Hietala, J.
    [J]. NEUROIMAGE, 2006, 31 : T127 - T128
  • [2] Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-11C]WAY-100635 -: considerations on the validity of cerebellum as a reference region
    Hirvonen, Jussi
    Kajander, Jaana
    Allonen, Topias
    Oikonen, Vesa
    Nagren, Kjell
    Hietala, Jarmo
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2007, 27 (01): : 185 - 195
  • [3] Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET
    Gunn, RN
    Sargent, PA
    Bench, CJ
    Rabiner, EA
    Osman, S
    Pike, VW
    Hume, SP
    Grasby, PM
    Lammertsma, AA
    [J]. NEUROIMAGE, 1998, 8 (04) : 426 - 440
  • [4] Brain serotonin 5-HT1A receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635
    Tauscher, J
    Kapur, S
    Verhoeff, NPLG
    Hussey, DF
    Daskalakis, ZJ
    Tauscher-Wisniewski, S
    Wilson, AA
    Houle, S
    Kasper, S
    Zipursky, RB
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (06) : 514 - 520
  • [5] PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain
    L. Farde
    Nathalie Ginovart
    Hiroshi Ito
    Camilla Lundkvist
    Victor W. Pike
    Julie A. McCarron
    Christer Halldin
    [J]. Psychopharmacology, 1997, 133 : 196 - 202
  • [6] Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635
    Cleare, AJ
    Messa, C
    Rabiner, EA
    Grasby, PM
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (03) : 239 - 246
  • [7] [C-11] WAY-100635 - A RADIOLIGAND FOR IMAGING 5-HT1A RECEPTORS WITH POSITRON EMISSION TOMOGRAPHY
    MATHIS, CA
    SIMPSON, NR
    MAHMOOD, K
    KINAHAN, PE
    MINTUN, MA
    [J]. LIFE SCIENCES, 1994, 55 (20) : PL403 - PL407
  • [8] Central 5-HT1A Receptor Binding in Patients with Alzheimer's Disease and Healthy Controls Examined with PET and [carbonyl-11C]WAY-100635
    Andree, B.
    Mattsson, P.
    Farde, L.
    Halldin, C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S22 - S22
  • [9] 5-HT1B receptor gene status alters 5-HT1A binding as investigated in vivo by [carbonyl-11C]WAY-100635 PET
    Kraus, C.
    Vanicek, T.
    Wadsak, W.
    Baldinger, P.
    Hartmann, A.
    Mitterhauser, M.
    Ungersboeck, J.
    Rujescu, D.
    Kasper, S.
    Lanzenberger, R.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S197 - S198
  • [10] Persistent reduction in brain 5-HT1A receptor binding in recovered depressed men using positron emission tomography and [11C]WAY-100635
    Bhagwagar, Z
    Rabiner, EA
    Sargent, PA
    Grasby, R
    Cowen, PJ
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S185 - S185